Journey Advisory Group, LLC Eli Lilly & CO Transaction History

Journey Advisory Group, LLC

$863 Million
Q3 2024

A detailed history of Journey Advisory Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Journey Advisory Group, LLC holds 24,805 shares of LLY stock, worth $19.7 Million. This represents 2.55% of its overall portfolio holdings.

Number of Shares

24,805

Previous 24,817 0.05%

Holding current value

$19.7 Million

Previous $22.5 Million 2.19%

% of portfolio

2.55%

Previous 2.69%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $9,265 - $11,520	-12 Reduced 0.05%	24,805 $22 Million
Q2 2024 Aug 02, 2024	SELL	$724.87 - $909.04 $3.35 Million - $4.2 Million	-4,623 Reduced 15.7%	24,817 $22.5 Million
Q1 2024 May 09, 2024	BUY	$592.2 - $792.28 $368,348 - $492,798	622 Added 2.16%	29,440 $22.9 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $152,305 - $179,547	-290 Reduced 1.0%	28,818 $16.8 Million
Q3 2023 Nov 15, 2023	SELL	$434.7 - $599.3 $216,915 - $299,050	-499 Reduced 1.69%	29,108 $15.6 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $252,182 - $337,196	-719 Reduced 2.37%	29,607 $13.9 Million
Q1 2023 May 04, 2023	BUY	$310.63 - $364.82 $453,830 - $533,002	1,461 Added 5.06%	30,326 $10.4 Million
Q4 2022 Feb 07, 2023	BUY	$321.55 - $374.67 $1.25 Million - $1.46 Million	3,900 Added 15.62%	28,865 $10.6 Million
Q3 2022 Nov 09, 2022	BUY	$296.48 - $337.87 $667,376 - $760,545	2,251 Added 9.91%	24,965 $8.07 Million
Q2 2022 Aug 02, 2022	BUY	$278.73 - $327.27 $1.25 Million - $1.47 Million	4,497 Added 24.69%	22,714 $7.36 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $437,931 - $544,237	1,866 Added 11.41%	18,217 $5.22 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $112,200 - $139,240	499 Added 3.15%	16,351 $4.52 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $84,208 - $103,629	-380 Reduced 2.34%	15,852 $3.66 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $73,122 - $94,583	405 Added 2.56%	16,232 $3.73 Million
Q1 2021 May 11, 2021	BUY	$164.32 - $212.72 $67,206 - $87,002	409 Added 2.65%	15,827 $2.96 Million
Q4 2020 Jan 19, 2021	BUY	$130.46 - $172.63 $2.01 Million - $2.66 Million	15,418 New	15,418 $2.6 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Journey Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Journey Advisory Group, LLC with notifications on news.

Account

Journey Advisory Group, LLC Eli Lilly & CO Transaction History